Cargando…
Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883541/ https://www.ncbi.nlm.nih.gov/pubmed/34788983 http://dx.doi.org/10.3324/haematol.2021.279037 |
| _version_ | 1784659956375486464 |
|---|---|
| author | Albertsson-Lindblad, Alexandra Palsdottir, Thorgerdur Smedby, Karin E. Weibull, Caroline E. Glimelius, Ingrid Jerkeman, Mats |
| author_facet | Albertsson-Lindblad, Alexandra Palsdottir, Thorgerdur Smedby, Karin E. Weibull, Caroline E. Glimelius, Ingrid Jerkeman, Mats |
| author_sort | Albertsson-Lindblad, Alexandra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8883541 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88835412022-03-18 Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017 Albertsson-Lindblad, Alexandra Palsdottir, Thorgerdur Smedby, Karin E. Weibull, Caroline E. Glimelius, Ingrid Jerkeman, Mats Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-11-18 /pmc/articles/PMC8883541/ /pubmed/34788983 http://dx.doi.org/10.3324/haematol.2021.279037 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Albertsson-Lindblad, Alexandra Palsdottir, Thorgerdur Smedby, Karin E. Weibull, Caroline E. Glimelius, Ingrid Jerkeman, Mats Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017 |
| title | Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017 |
| title_full | Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017 |
| title_fullStr | Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017 |
| title_full_unstemmed | Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017 |
| title_short | Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017 |
| title_sort | survival in mantle cell lymphoma after frontline treatment with r-bendamustine, r-chop and the nordic mcl2 regimen – a real world study on patients diagnosed in sweden 2007-2017 |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883541/ https://www.ncbi.nlm.nih.gov/pubmed/34788983 http://dx.doi.org/10.3324/haematol.2021.279037 |
| work_keys_str_mv | AT albertssonlindbladalexandra survivalinmantlecelllymphomaafterfrontlinetreatmentwithrbendamustinerchopandthenordicmcl2regimenarealworldstudyonpatientsdiagnosedinsweden20072017 AT palsdottirthorgerdur survivalinmantlecelllymphomaafterfrontlinetreatmentwithrbendamustinerchopandthenordicmcl2regimenarealworldstudyonpatientsdiagnosedinsweden20072017 AT smedbykarine survivalinmantlecelllymphomaafterfrontlinetreatmentwithrbendamustinerchopandthenordicmcl2regimenarealworldstudyonpatientsdiagnosedinsweden20072017 AT weibullcarolinee survivalinmantlecelllymphomaafterfrontlinetreatmentwithrbendamustinerchopandthenordicmcl2regimenarealworldstudyonpatientsdiagnosedinsweden20072017 AT glimeliusingrid survivalinmantlecelllymphomaafterfrontlinetreatmentwithrbendamustinerchopandthenordicmcl2regimenarealworldstudyonpatientsdiagnosedinsweden20072017 AT jerkemanmats survivalinmantlecelllymphomaafterfrontlinetreatmentwithrbendamustinerchopandthenordicmcl2regimenarealworldstudyonpatientsdiagnosedinsweden20072017 |